Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease ...

Swiss drugmaker Roche Holding plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high ...

(Reuters) -The U.S. Food and Drug Administration said on Friday it was investigating the death of an eight-year-old boy who ...

Posay's Effaclar A.Z. Gel-Cream is touted as a skincare unicorn. But is it really as good as everyone says it is?

DPIIT collaborates with Roche Products and HDFC Capital Advisors to support startups in healthcare and affordable housing ...

The city has endured blizzards, economic collapse and an NFL team that just can’t seem to win a Super Bowl. But natives who ...

Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer’s disease symptoms in high-risk people, ...

In a Phase Ib/IIa trial, 91% of patients receiving the highest dose of trontinemab were amyloid negative after seven months ...

Roche’s move came against a backdrop of wider industry retreat from gene therapy, with Pfizer pulling its FDA-approved ...

Follow live text commentary, score updates and match stats from Lausanne-Sport vs Vardar Skopje in the UEFA Conference League ...

Arsenal's tour ended in defeat to their north London rivals - with two friendlies left before the season starts, how are they ...

Roche’s Alzheimer’s disease therapy has continued to show benefit for patients after 28 weeks in a long-term extension study.